Y Intercept (Hong Kong) LTD Iovance Biotherapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $123,337 - $283,887	16,250 New	16,250 $240,000
Q2 2022 Aug 08, 2022	SELL	$6.38 - $18.33 $198,315 - $569,769	-31,084 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $384,819 - $593,704	31,084 New	31,084 $518,000
Q2 2021 Aug 12, 2021	SELL	$16.33 - $33.07 $307,216 - $622,145	-18,813 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$28.67 - $52.59 $395,703 - $725,847	13,802 Added 275.43%	18,813 $558,000
Q4 2020 Feb 05, 2021	BUY	$28.04 - $50.26 $140,508 - $251,852	5,011 New	5,011 $244,000

338

247M

2.52M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $879M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.